Norditropin (Novo Nordisk)
Welcome to the PulseAid listing for the Norditropin drug offered from Novo Nordisk. This Recombinant Human Growth Hormone [EPC],Recombinant Human Growth Hormones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novo Nordisk |
NON-PROPRIETARY NAME: | somatropin |
SUBSTANCE NAME: | SOMATROPIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Recombinant Human Growth Hormone [EPC],Recombinant Human Growth Hormones [Chemical/Ingredient] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-03-30 |
END MARKETING DATE: | 0000-00-00 |
Norditropin HUMAN PRESCRIPTION DRUG Details:
Item Description | Norditropin from Novo Nordisk |
LABELER NAME: | Novo Nordisk |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30(mg/3mL) |
START MARKETING DATE: | 2009-03-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0169-7703_c8b18e24-9ddd-4a1f-bfd0-ccaa7c00622d |
PRODUCT NDC: | 0169-7703 |
APPLICATION NUMBER: | NDA021148 |
Other SOMATROPIN Pharmaceutical Manufacturers / Labelers: